# Emerging RNA-centric technologies to probe RNA-protein interactions: importance in decoding the life cycle of positive sense single strand RNA viruses and antiviral discovery

**Authors:** Sreemoyee Ghosh, Shivam Kumar, Rohit Verma, Shabnam Ansari, Samrat Chatterjee, Milan Surjit

PMC · DOI: 10.3389/fcimb.2025.1580337 · 2025-05-21

## TL;DR

This review discusses new RNA-focused technologies for studying RNA-protein interactions in +ssRNA viruses, which could help in understanding their life cycle and developing antiviral treatments.

## Contribution

The paper reviews emerging technologies and their potential to advance antiviral discovery for +ssRNA viruses.

## Key findings

- RNA-protein interactions are crucial for the life cycle and pathogenesis of +ssRNA viruses.
- New computational and high-throughput technologies offer better tools for studying these interactions.
- These technologies can aid in the development of specific antiviral therapeutics.

## Abstract

Positive sense single strand RNA (+ssRNA) viruses are one of the evolutionary successful organisms and many of them pose a significant threat to human health. Diseases caused by +ssRNA viruses such as COVID-19, Flu and acute viral hepatitis are major public health concern worldwide. Therefore, a lot of research is focused at decoding the life cycle of +ssRNA viruses and develop specific antiviral therapeutics against them. Interaction of the viral RNA with virus-encoded proteins and host proteins drives the lifecycle and pathogenesis of +ssRNA viruses. Recent developments in computational and high-throughput omics-based experimental technologies offer the sensitivity and specificity for molecular characterization of these RNA-protein complexes. These are promising tools to revolutionize the field of +ssRNA virus research and pave the way for antiviral discovery. This review summarizes the current scientific resources available to characterize the RNA-protein interactome of +ssRNA viruses and provides an overview of the drug discovery pipeline for developing antivirals against pathogenic +ssRNA viruses.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096), Flu (MONDO:0005812)

## Full-text entities

- **Diseases:** Flu (MESH:D007251), acute viral hepatitis (MESH:D006525), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12204112/full.md

---
Source: https://tomesphere.com/paper/PMC12204112